Literature DB >> 10517976

Characterization of genetic instability in radiation- and benzene-induced murine acute leukemia.

K Rithidech1, J J Dunn, V P Bond, C R Gordon, E P Cronkite.   

Abstract

This study, using the CBA/Ca mouse as a model, compares genetic lesions associated with radiation- and benzene-induced acute leukemias. Specific types of leukemia included in the analyses are radiation-induced acute myeloid leukemia (ML), and benzene-induced lymphoblastic leukemias, lymphomas, or mix-lineage leukemias. These leukemias have histopathological characteristics similar to those seen in human acute leukemias. G-band cytogenetic analysis showed that specific deletions involving regions D-E of one copy of mouse chromosome 2 [del(2)(D-E)] were frequently associated in both radiation- and benzene-induced acute leukemias. In addition, translocations of chr2(D-E) were also observed in some cases. These results suggest an important role of chr2 (D-E) deletions and translocations in the development of radiation- and benzene-induced murine acute leukemias. Fluorescence in situ hybridization with DNA probes specific for 2(D-E), constructed in our laboratory by means of chromosomal microdissection and PCR amplification, also demonstrate 2(D-E) deletions and/or translocations in these leukemic cells. Aneuploidy of chromosomes 3, 15, 16, and Y were also frequently detected in benzene-induced leukemic cells with or without lesions on chr2. These cytogenetic findings support the previous observations that metabolites of benzene lead to spindle-fiber disruption or abnormal cytokinesis in exposed animals. In summary, genetic instabilities observed in leukemic cells isolated from mice that had developed leukemia after exposure to radiation or benzene are syntenic with those frequently detected in patients with myelodysplastic syndrome, acute ML, and acute lymphoblastic leukemia. Thus, the CBA/Ca mouse has several characteristics that make it an excellent model for the study of radiation or benzene leukemogenesis in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517976     DOI: 10.1016/s1383-5742(99)00029-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.

Authors:  Matthew J Walter; John S Park; Rhonda E Ries; Steven K M Lau; Michael McLellan; Sara Jaeger; Richard K Wilson; Elaine R Mardis; Timothy J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-19       Impact factor: 11.205

2.  Expression of a bcr-1 isoform of RARalpha-PML does not affect the penetrance of acute promyelocytic leukemia or the acquisition of an interstitial deletion on mouse chromosome 2.

Authors:  Matthew J Walter; Rhonda E Ries; Jon R Armstrong; John S Park; Elaine R Mardis; Timothy J Ley
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

Review 3.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

Review 4.  Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review.

Authors:  Leena Rivina; Robert Schiestl
Journal:  Int J Environ Res Public Health       Date:  2012-12-27       Impact factor: 3.390

Review 5.  Radiation-induced myeloid leukemia in murine models.

Authors:  Leena Rivina; Michael Davoren; Robert H Schiestl
Journal:  Hum Genomics       Date:  2014-07-25       Impact factor: 4.639

Review 6.  A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology.

Authors:  Hala Skayneh; Batoul Jishi; Rita Hleihel; Maguy Hamieh; Nadine Darwiche; Ali Bazarbachi; Marwan El Sabban; Hiba El Hajj
Journal:  Genes (Basel)       Date:  2019-08-13       Impact factor: 4.096

7.  Rapid and reliable diagnosis of murine myeloid leukemia (ML) by FISH of peripheral blood smear using probe of PU. 1, a candidate ML tumor suppressor.

Authors:  Reiko Kanda; Satsuki Tsuji; Yasushi Ohmachi; Yuka Ishida; Nobuhiko Ban; Yoshiya Shimada
Journal:  Mol Cytogenet       Date:  2008-10-16       Impact factor: 2.009

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.